Stability of Melphalan in 0.9 % Sodium Chloride Solutions Prepared in Polyvinyl Chloride Bags for Intravenous Injection

Por Desmaris, Romain-Pacôme, Mercier, Lionel, Paci, Angelo
Publicado no Drugs R D (2015)

Insights into significance of combined inhibition of MEK and m-TOR signalling output in KRAS mutant non-small-cell lung cancer

Por Broutin, Sophie, Stewart, Adam, Thavasu, Parames, Paci, Angelo, Bidart, Jean-Michel, Banerji, Udai
Publicado no Br J Cancer (2016)

Physico-Chemical Stability of Busulfan in Injectable Solutions in Various Administration Packages

Por Houot, Mélanie, Poinsignon, Vianney, Mercier, Lionel, Valade, Cyril, Desmaris, Romain, Lemare, François, Paci, Angelo
Publicado em 2013

Stability of Etoposide Solutions in Disposable Infusion Devices for Day Hospital Cancer Practices

Por Klasen, Alison, Kessari, Romain, Mercier, Lionel, Valade, Cyril, Grill, Jacques, Desmaris, Romain, Paci, Angelo
Publicado em 2014

The Lack of Antitumor Effects of o,p′DDA Excludes Its Role as an Active Metabolite of Mitotane for Adrenocortical Carcinoma Treatment

Por Hescot, Ségolène, Paci, Angelo, Seck, Atmane, Slama, Abdelhamid, Viengchareun, Say, Trabado, Séverine, Brailly-Tabard, Sylvie, Al Ghuzlan, Abir, Young, Jacques, Baudin, Eric, Lombès, Marc
Publicado no Horm Cancer (2014)

Dyslipidemia causes overestimation of plasma mitotane measurements

Por Paci, Angelo, Hescot, Ségolène, Seck, Atmane, Jublanc, Christel, Mercier, Lionel, Vezzosi, Delphine, Drui, Delphine, Quinkler, Marcus, Fassnacht, Martin, Bruckert, Eric, Lombès, Marc, Leboulleux, Sophie, Broutin, Sophie, Baudin, Eric
Publicado no Endocrinol Diabetes Metab Case Rep (2016)

Phase I clinical trial combining imatinib mesylate and IL-2 in refractory cancer patients: IL-2 interferes with the pharmacokinetics of imatinib mesylate

Por Pautier, Patricia, Locher, Clara, Robert, Caroline, Deroussent, Alain, Flament, Caroline, Le Cesne, Axel, Rey, Annie, Bahleda, Ratislav, Ribrag, Vincent, Soria, Jean-Charles, Vassal, Gilles, Eggermont, Alexander, Zitvogel, Laurence, Chaput, Nathalie, Paci, Angelo
Publicado em 2013

Phase I clinical trial combining imatinib mesylate and IL-2: HLA-DR(+) NK cell levels correlate with disease outcome

Por Chaput, Nathalie, Flament, Caroline, Locher, Clara, Desbois, Mélanie, Rey, Annie, Rusakiewicz, Sylvie, Poirier-Colame, Vichnou, Pautier, Patricia, Le Cesne, Axel, Soria, Jean-Charles, Paci, Angelo, Rosenzwajg, Michelle, Klatzmann, David, Eggermont, Alexander, Robert, Caroline, Zitvogel, Laurence
Publicado em 2013

EPT-01 DOSE-FINDING STUDY OF VINBLASTINE IN COMBINATION WITH NILOTINIB IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH REFRACTORY OR RECURRENT LOW-GRADE GLIOMA: RESULTS OF THE ITCC/...

Por Grill, Jacques, Le Deley, Marie-Cecile, Le Teuff, Gwenael, Abbou, Samuel, Geoerger, Birgit, Bautista-Sirvent, Francisco, Malekzadeh, Katia, Paci, Angelo, De Carli, Emilie, Bertozzi, Anne-Isabelle, Pagnier, Anne, Doz, Francois, Leblond, Pierre, Millot, Frederic, Dufour, Christelle, Berger, Claire, Fouyssac, Fanny, Nysom, Karsten, Vassal, Gilles
Publicado no Neuro Oncol (2016)

The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development

Por Lemonnier, François, Cairns, Rob A., Inoue, Satoshi, Li, Wanda Y., Dupuy, Aurélie, Broutin, Sophie, Martin, Nadine, Fataccioli, Virginie, Pelletier, Romain, Wakeham, Andrew, Snow, Bryan E., de Leval, Laurence, Pujals, Anais, Haioun, Corinne, Paci, Angelo, Tobin, Erica R., Narayanaswamy, Rohini, Yen, Katherine, Jin, Shengfang, Gaulard, Philippe, Mak, Tak W.
Publicado no Proc Natl Acad Sci U S A (2016)